Literature DB >> 25025464

Shear-wave elastography: a noninvasive tool for monitoring changing hepatic venous pressure gradients in patients with cirrhosis.

Seo-Youn Choi1, Woo Kyoung Jeong, Yongsoo Kim, Jinoo Kim, Tae Yeob Kim, Joo Hyun Sohn.   

Abstract

PURPOSE: To investigate whether liver stiffness ( LS liver stiffness ) and change in LS liver stiffness measurements ( ΔLS change in LS ) at shear-wave elastography ( SWE shear-wave elastography ) correlates with the hepatic venous pressure gradient ( HVPG hepatic venous pressure gradient ) and to assess the feasibility of using SWE shear-wave elastography to estimate the change in HVPG hepatic venous pressure gradient ( ΔHVPG change in HVPG ) in patients with portal hypertension.
MATERIALS AND METHODS: Institutional review board approval was obtained, with waiver of informed consent. Between September 2010 and October 2012, 97 consecutive patients who were given a diagnosis of portal hypertension on the basis of HVPG hepatic venous pressure gradient measurement were included. Among these patients, 23 who underwent follow-up HVPG hepatic venous pressure gradient measurement to evaluate response to treatment were included in the follow-up group. The correlation between HVPG hepatic venous pressure gradient and LS liver stiffness was analyzed by using the Pearson correlation test. In the follow-up group, whether ΔHVPG change in HVPG was correlated with ΔLS change in LS was also evaluated. Thereafter, the areas under the receiver operating characteristic curves ( AUC area under the ROC curve s) were calculated to determine the diagnostic performances of ΔLS change in LS and the second LS liver stiffness measurement after medical treatment and to compare their performances in association with clinical improvement and aggravation of portal hypertension.
RESULTS: LS liver stiffness was moderately correlated with HVPG hepatic venous pressure gradient (r = 0.593) in the single-measurement group. There was also a strong correlation between ΔLS change in LS and ΔHVPG change in HVPG (r = 0.863). At comparison of the second LS liver stiffness measurement, ΔLS change in LS showed no significant difference in AUC area under the ROC curve in patients with improvement (0.627 vs 0.794, P = .201) but showed higher AUC area under the ROC curve in association with aggravation of portal hypertension (0.925 vs 0.611, P = .026).
CONCLUSION: Estimating ΔHVPG change in HVPG by using SWE shear-wave elastography may be useful in patients with cirrhosis and portal hypertension. © RSNA, 2014.

Entities:  

Mesh:

Year:  2014        PMID: 25025464     DOI: 10.1148/radiol.14140008

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  21 in total

1.  Clinical role of non-invasive assessment of portal hypertension.

Authors:  Massimo Bolognesi; Marco Di Pascoli; David Sacerdoti
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

2.  Shear-wave elastography of the ulnar collateral ligament of the elbow in healthy volunteers: a pilot study.

Authors:  Nakul Gupta; John S Labis; Joshua Harris; Michael A Trakhtenbroit; Leif E Peterson; Robert A Jack; Patrick C McCulloch
Journal:  Skeletal Radiol       Date:  2019-01-31       Impact factor: 2.199

3.  An evaluation of the objectivity and reproducibility of shear wave elastography in estimating the post-mortem interval: a tissue biomechanical perspective.

Authors:  Fabio De-Giorgio; Gabriele Ciasca; Ronel D'Amico; Pietro Trombatore; Anna D'Angelo; Pierluigi Rinaldi; Filippo Milano; Emanuela Locci; Marco De Spirito; Ernesto d'Aloja; Cesare Colosimo; Vincenzo L Pascali
Journal:  Int J Legal Med       Date:  2020-07-17       Impact factor: 2.686

Review 4.  Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease.

Authors:  Michelle T Long; Sanil Gandhi; Rohit Loomba
Journal:  Metabolism       Date:  2020-05-05       Impact factor: 8.694

Review 5.  Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions.

Authors:  Paul Kennedy; Mathilde Wagner; Laurent Castéra; Cheng William Hong; Curtis L Johnson; Claude B Sirlin; Bachir Taouli
Journal:  Radiology       Date:  2018-03       Impact factor: 11.105

6.  Performance of 2-Dimensional Ultrasound Shear Wave Elastography in Liver Fibrosis Detection Using Magnetic Resonance Elastography as the Reference Standard: A Pilot Study.

Authors:  Pengfei Song; Daniel C Mellema; Shannon P Sheedy; Duane D Meixner; Ryan M Karshen; Matthew W Urban; Armando Manduca; William Sanchez; Matthew R Callstrom; James F Greenleaf; Shigao Chen
Journal:  J Ultrasound Med       Date:  2016-01-18       Impact factor: 2.153

7.  Spleen stiffness-spleen size-to-platelet ratio risk score as noninvasive predictors of esophageal varices in patients with hepatitis B virus-related cirrhosis.

Authors:  Young Seo Cho; Sanghyeok Lim; Yongsoo Kim; Min Hee Lee; Seo-Youn Choi; Ji Eun Lee
Journal:  Medicine (Baltimore)       Date:  2022-05-27       Impact factor: 1.817

8.  Hepatic stiffness measurement by using MR elastography: prognostic values after hepatic resection for hepatocellular carcinoma.

Authors:  Dong Ho Lee; Jeong Min Lee; Nam-Joon Yi; Kwang-Woong Lee; Kyung-Suk Suh; Jeong-Hoon Lee; Kyung Bun Lee; Joon Koo Han
Journal:  Eur Radiol       Date:  2016-07-25       Impact factor: 5.315

9.  Liver Stiffness Measured by Two-Dimensional Shear-Wave Elastography: Prognostic Value after Radiofrequency Ablation for Hepatocellular Carcinoma.

Authors:  Dong Ho Lee; Jeong Min Lee; Jung-Hwan Yoon; Yoon Jun Kim; Jeong-Hoon Lee; Su Jong Yu; Joon Koo Han
Journal:  Liver Cancer       Date:  2018-01-12       Impact factor: 11.740

10.  Using MR elastography to assess portal hypertension and response to beta-blockers in patients with cirrhosis.

Authors:  Karen Vagner Danielsen; Jens Dahlgaard Hove; Puria Nabilou; Meng Yin; Jun Chen; Mirabella Zhao; Thomas Kallemose; Ane Søgaard Teisner; Hartwig Roman Siebner; Richard L Ehman; Søren Møller; Flemming Bendtsen
Journal:  Liver Int       Date:  2021-06-16       Impact factor: 8.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.